Thomas Ottoboni

Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain

Thomas Ottoboni, Barry Quart, Jayne Pawasauskas et al. · Regional Anesthesia & Pain Medicine · 2019 · 51 citations · Full text

Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron

Thomas Ottoboni, Mark Gelder, Erin O’Boyle · Journal of Experimental Pharmacology · 2014 · 38 citations · Full text

Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation

Thomas Ottoboni, Mary Rose Keller, Matt Cravets et al. · Drug Design Development and Therapy · 2018 · 23 citations · Full text

Hypersensitivity and Infusion-Site Adverse Events with Intravenous Fosaprepitant after Anthracycline-Containing Chemotherapy: A Retrospective Study

Ralph V. Boccia, Robert B. Geller, Neil J. Clendeninn et al. · Future Oncology · 2018 · 17 citations · Full text

HTX-019 via 2-Min Injection or 30-Min Infusion in Healthy Subjects

Thomas Ottoboni, Michael Lauw, Mary Rose Keller et al. · Future Oncology · 2018 · 11 citations · Full text